ASH - Blood Disorders

The Causes of Sickle Cell Disease and Beta-thalassemias
The Causes of Sickle Cell Disease and Beta-thalassemias
Common Manifestations of Congenital Plasminogen Deficiency
Common Manifestations of Congenital Plasminogen Deficiency
The Benefit of Maintaining the Expression of the Anti-sickling Damma Ortholog in Patients With Sickle Cell Disease and Beta-thalassemias
The Benefit of Maintaining the Expression of the Anti-sickling Damma Ortholog in Patients With Sickle Cell Disease and Beta-thalassemias
Understanding Parallel Target Identification Efforts in the Induction of Fetal Hemoglobin
Understanding Parallel Target Identification Efforts in the Induction of Fetal Hemoglobin
The Diagnosis Process for Patients With Congenital Plasminogen Deficiency
The Diagnosis Process for Patients With Congenital Plasminogen Deficiency
The Development and Treatment Potential of FTX-6058
The Development and Treatment Potential of FTX-6058
Treatment for Patients With Congenital Plasminogen Deficiency With Airway Obstruction and Respiratory Distress
Treatment for Patients With Congenital Plasminogen Deficiency With Airway Obstruction and Respiratory Distress
Patient Response to Treatment With FTX-6058
Patient Response to Treatment With FTX-6058
The Significance of 3 New Patient Cases in Understanding Congenital Plasminogen Deficiency
The Significance of 3 New Patient Cases in Understanding Congenital Plasminogen Deficiency
How Airway Obstruction and Respiratory Distress Can Impact Pediatric Patients Versus Adult Patients With Congenital Plasminogen Deficiency
How Airway Obstruction and Respiratory Distress Can Impact Pediatric Patients Versus Adult Patients With Congenital Plasminogen Deficiency
Closing Thoughts on Research into the Induction of Fetal Hemoglobin by FTX6058
Closing Thoughts on Research into the Induction of Fetal Hemoglobin by FTX6058
Overview and Highlights of the RESET Clinical Trial
Overview and Highlights of the RESET Clinical Trial